We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-1.89%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$154M
AUM Growth
-$90.8M
Cap. Flow
-$89.2M
Cap. Flow %
-57.92%
Top 10 Hldgs %
20.11%
Holding
827
New
297
Increased
13
Reduced
39
Closed
409

Sector Composition

Rank Sector Weight
1 Financials 21.13%
2 Technology 16.45%
3 Healthcare 14.29%
4 Industrials 11.13%
5 Consumer Discretionary 10.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHD
626
DELISTED
Pioneer Floating Rate Fund
PHD
-84,736
Closed -$820K
PHM icon
627
Pultegroup
PHM
$25.2B
-8,599
Closed -$936K
PHVS icon
628
Pharvaris
PHVS
$2.28B
-3,738
Closed -$71.7K
PLRX icon
629
Pliant Therapeutics
PLRX
$65M
-5,133
Closed -$67.6K
PLTR icon
630
Palantir
PLTR
$295B
-25,585
Closed -$1.93M
PNNT
631
Pennant Park Investment Corp
PNNT
$220M
-132,692
Closed -$939K
PRAX icon
632
Praxis Precision Medicines
PRAX
$8.11B
-1,001
Closed -$77K
PRME icon
633
Prime Medicine
PRME
$547M
-23,618
Closed -$69K
PRTA icon
634
Prothena Corp
PRTA
$448M
-5,148
Closed -$71.3K
PSA icon
635
Public Storage
PSA
$61.5B
-3,910
Closed -$1.17M
PSEC icon
636
Prospect Capital
PSEC
$1.08B
-279,372
Closed -$1.2M
PTCT icon
637
PTC Therapeutics
PTCT
$6.18B
-7,383
Closed -$333K
PTEN icon
638
Patterson-UTI
PTEN
$3.54B
-21,130
Closed -$175K
PTGX icon
639
Protagonist Therapeutics
PTGX
$8.55B
-1,761
Closed -$68K
BCIC
640
BCP Investment Corp
BCIC
$88.3M
-29,852
Closed -$488K
PWR icon
641
Quanta Services
PWR
$84.2B
-3,671
Closed -$1.16M
PYPL icon
642
PayPal
PYPL
$49.9B
-13,763
Closed -$1.17M
QURE icon
643
uniQure
QURE
$2.78B
-4,721
Closed -$83.4K
RARE icon
644
Ultragenyx Pharmaceutical
RARE
$2.46B
-7,457
Closed -$314K
RCKT icon
645
Rocket Pharmaceuticals
RCKT
$343M
-5,656
Closed -$71.1K
RCL icon
646
Royal Caribbean
RCL
$86.5B
-5,653
Closed -$1.3M
RCUS icon
647
Arcus Biosciences
RCUS
$3.33B
-4,143
Closed -$61.7K
REG icon
648
Regency Centers
REG
$14.9B
-2,470
Closed -$183K
REGN icon
649
Regeneron Pharmaceuticals
REGN
$72.9B
-472
Closed -$336K
REPL icon
650
Replimune Group
REPL
$455M
-5,818
Closed -$70.5K

Similar funds

Virtus ETF Advisers's Q1 2025 Portfolio in Review

As of Q1 2025, Virtus ETF Advisers held 827 positions worth $154M, down 37% from $245M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Virtus ETF Advisers withdrew a net $89.2M in Q1 2025, closing 409 positions and reducing 39 holdings. Its most notable exit was OFS Credit Co, an estimated $2.26M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Virtus ETF Advisers opened a new position in ICICI Bank worth $8.23M.

  • Virtus ETF Advisers's largest Q1 2025 buy was ICICI Bank: 261,046 shares worth $8.23M.
  • Virtus ETF Advisers added most to Microsoft in Q1 2025, an estimated $1.1M increase.
  • Virtus ETF Advisers's biggest Q1 2025 reduction was Fortinet, cutting an estimated $1.33M.
  • Virtus ETF Advisers fully exited OFS Credit Co in Q1 2025, selling an estimated $2.26M.
  • Virtus ETF Advisers's ten largest holdings make up 20% of its $154M portfolio in Q1 2025.
  • Virtus ETF Advisers opened 297 new positions and closed 409 in Q1 2025.
  • Virtus ETF Advisers's portfolio value fell 37% quarter-over-quarter to $154M.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.